Noxopharm Limited (NOX.AX)
AUD 0.08
(2.67%)
AUD 0.08
(2.67%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -3.57 Million AUD | 76.24% |
| 2023 | -15.05 Million AUD | 19.34% |
| 2022 | -18.66 Million AUD | -99.71% |
| 2021 | -9.34 Million AUD | -3335.13% |
| 2020 | -272.09 Thousand AUD | 97.58% |
| 2019 | -11.22 Million AUD | 38.62% |
| 2018 | -18.28 Million AUD | -500.27% |
| 2017 | -3.04 Million AUD | -332.21% |
| 2016 | -704.72 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -3.57 Million AUD | 76.24% |
| 2024 Q4 | -1.08 Million AUD | 0.0% |
| 2024 Q2 | -2.49 Million AUD | 0.0% |
| 2023 Q2 | -5.42 Million AUD | 0.0% |
| 2023 Q4 | -9.62 Million AUD | 0.0% |
| 2023 FY | -15.05 Million AUD | 19.34% |
| 2022 FY | -18.66 Million AUD | -99.71% |
| 2022 Q2 | -8.61 Million AUD | 0.0% |
| 2022 Q4 | -10.05 Million AUD | 0.0% |
| 2021 Q2 | -6.72 Million AUD | 0.0% |
| 2021 FY | -9.34 Million AUD | -3335.13% |
| 2021 Q4 | -2.62 Million AUD | 0.0% |
| 2020 Q2 | -6.94 Million AUD | 0.0% |
| 2020 FY | -272.09 Thousand AUD | 97.58% |
| 2020 Q4 | 6.67 Million AUD | 0.0% |
| 2019 Q4 | -6.76 Million AUD | 0.0% |
| 2019 FY | -11.22 Million AUD | 38.62% |
| 2019 Q2 | -3.59 Million AUD | 0.0% |
| 2018 Q4 | -6.29 Million AUD | 0.0% |
| 2018 FY | -18.28 Million AUD | -500.27% |
| 2018 Q2 | -11.99 Million AUD | 0.0% |
| 2017 Q3 | -761.47 Thousand AUD | 33.15% |
| 2017 FY | -3.04 Million AUD | -332.21% |
| 2017 Q2 | -1.13 Million AUD | 0.0% |
| 2017 Q4 | -1.9 Million AUD | -150.41% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | -704.72 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 33.508% |
| Acrux Limited | -5.8 Million AUD | 38.308% |
| Actinogen Medical Limited | -13.04 Million AUD | 72.569% |
| AnteoTech Limited | -8.88 Million AUD | 59.708% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 34.7% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 59.089% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -146.556% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 81.289% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 20.547% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -4.119% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -48.52% |
| Biome Australia Limited | -1.67 Million AUD | -114.233% |
| Biotron Limited | -3.43 Million AUD | -4.12% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 74.202% |
| BTC Health Limited | 1.05 Million AUD | 439.066% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 71.443% |
| CSL Limited | 2.64 Billion AUD | 100.135% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 91.546% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 110.041% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 63.281% |
| Dimerix Limited | -17.07 Million AUD | 79.045% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 151.377% |
| Hexima Limited | -933.87 Thousand AUD | -283.148% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -24.92% |
| Immuron Limited | -6.93 Million AUD | 48.42% |
| Immutep Limited | -39.89 Million AUD | 91.031% |
| Imugene Limited | -149.68 Million AUD | 97.609% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -117.937% |
| Memphasys Limited | -4.44 Million AUD | 19.448% |
| Nanollose Limited | -1.15 Million AUD | -209.378% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 102.278% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 1203.642% |
| Nyrada Inc. | -1.38 Million AUD | -158.119% |
| Orthocell Limited | -7.18 Million AUD | 50.172% |
| PharmAust Limited | -9.03 Million AUD | 60.386% |
| Patrys Limited | -3.53 Million AUD | -1.101% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 93.9% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 43.883% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 56.566% |
| PYC Therapeutics Limited | -37.72 Million AUD | 90.515% |
| Race Oncology Limited | -13.81 Million AUD | 74.108% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 92.538% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 79.741% |
| Starpharma Holdings Limited | -8.16 Million AUD | 56.177% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 168.665% |
| Tissue Repair Ltd | -4.13 Million AUD | 13.532% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 90.215% |